论文部分内容阅读
医药主题类基金的良好业绩表现,主要得益于医药生物板块的强势表现。申万医药生物指数涨幅达21.45%,远好于同期沪深300指数-14.56%的收益。去年以来,医药主题类基金表现优异。截至3月18日,除今年新成立的3只医药主题类基金外,市场中正在运作的医药主题类基金共有6只,分别为富国医疗保健行业、融通医疗保健行业、博时医疗保健行业、汇添富医药保健、华宝兴业医药生物和易方达医疗保健。医药主题类基金整体表现不俗,优于同期的股票型基金。医药主题
The good performance of the pharmaceutical theme funds was mainly due to the strong performance of the pharmaceutical bio-segment. Shen million pharmaceutical bio index rose 21.45%, far better than the CSI 300 Index -14.56% of the proceeds. Since last year, the pharmaceutical theme fund has performed outstandingly. As of March 18, in addition to the three new pharmaceutical theme funds set up this year, there are six pharmaceutical theme funds currently in operation in the market, namely the rich healthcare industry, the healthcare intermediary industry, the Boshi health care industry, Tianfu medicine health care, Fortune SGAM biological and E Fund health care. The overall performance of the pharmaceutical theme fund is impressive, outperforming the stock funds of the same period. Medicine theme